ECOG endorses Springer IME’s new Adolescent Obesity Gamefied Module
ECOG is delighted to endorse and support the independent medical educational program “Rethinking obesity in adolescents” by Springer Healthcare IME.
This expert-led program aims to support you with the individualized management of obesity in adolescents through education on the importance of early detection and intervention; how to develop tailored management plans including the appropriate incorporation of AOMs; and managing the psychological and social factors influencing treatment adherence.
Test your management skills
Put your adolescent obesity management knowledge to the test with management match-up, the interactive game in which you are tasked with matching the most appropriate patients to the management plans provided. Daniel Weghuber, Caroline Braet and Michael Vallis provide their expert commentary on your choices – will you choose correctly?
Available at: https://adolescent-obesity.ime.springerhealthcare.com/module/adolescent-obesity-management-match-up/
Hear from our experts
Daniel Weghuber and Caroline Braet discuss the individual and societal burden of adolescent obesity, including unique challenges faced by the adolescent population and strategies to overcome them in this latest expert discussion video module.
Available at: Video discussion: Burden, barriers, and unmet needs | Rethinking obesity in adolescents (springerhealthcare.com)
Learning objectives
Following completion of this independent educational program, you will be able to:
1. Describe the chronic burden of obesity in adolescents and the need for proactive intervention
2. Integrate pharmacological therapies alongside lifestyle interventions, where appropriate
3. Develop strategies to support individualized management strategies based on patient motivators and barriers
Funding
The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs.
Supported by an educational grant from NOVO NORDISK A/S.
